RepliCel Life Sciences products

RCS-01 is a proprietary autologous cell therapy being developed to rejuvenate aging or UV-damaged skin.* *This product is currently in clinical testing and not yet commercially available. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are involved in generating and maintaining healthy connective tissue, fibroblasts play a critical role by expressing many types of tissue-building proteins. The NBDS cells which are the focus of RepliCel`s patented technologies, are the most prolific generators of collagen (Type 1 and 2) of any fibroblasts found anywhere in the body. These cells are responsible for generating the fast-growing tissue of the hair follicle every time a new follicle is generated as part of its regular cycle.

RCT-01 is a proprietary autologous cell therapy being developed to treat chronically damaged tendons. * *This product is currently in clinical testing and not yet commercially available. RCT-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are involved in generating and maintaining healthy connective tissue, fibroblasts play a critical role by expressing many types of tissue-building proteins. The NBDS cells which are the focus of RepliCel`s patented technologies, are the most prolific generators of collagen (Type 1 and 2) of any fibroblasts found anywhere in the body. These cells are responsible for generating the fast-growing tissue of the hair follicle every time a new follicle is generated as part of its regular cycle.

RCH-01 is a proprietary autologous cell therapy being developed to treat pattern baldness.* *This product is currently in clinical testing and not yet commercially available. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. Though several cell types are involved, dermal sheath cup cells, located at base of the hair follicle, regulate the growth of hair fibres in the follicle. For those people suffering from androgenetic alopecia, the DHT hormone attacks these cells and as they disappear so does the hair fibre. At the back of the head, however, these cells are immune to the condition.

DermaPrecise is our next-generation dermal injector. DermaPrecise™ is the world`s first motorized injection device with programmable depth and volume, a built-in Peltier element for pre-injection numbing of the skin and interchangeable needle head configurations. It is designed to deliver a variety of injectable substances in and under the skin with an array of needle configurations, ranging from a single needle to a 16-needle configuration (4x4) on one head. These interchangeable heads can be used to perform a variety of procedures, increase surface area coverage and speed-up procedure times.